Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason H Kurzer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Blood|September 1, 2022
Visceral leishmaniasis in the differential diagnosis of pancytopeniaYong Tang, Jason H Kurzer
Surgical Pathology Clinics|July 30, 2019
Acute Leukemias of Ambiguous Lineage: Clarification on Lineage SpecificityJason H Kurzer, Olga K Weinberg
Seminars in Diagnostic Pathology|April 14, 2023
Updates in molecular genetics of acute myeloid leukemiaJason H Kurzer, Olga K Weinberg
Frontiers in Oncology|August 12, 2021
<i>PHF6</i> Mutations in Hematologic MalignanciesJason H Kurzer, Olga K Weinberg
Journal of Clinical Pathology|May 27, 2018
Identification of early B cell precursors (stage 1 and 2 hematogones) in the peripheral bloodJason H Kurzer, Olga K Weinberg
International Journal of Laboratory Hematology|June 30, 2022
To B- or not to B-: A review of lineage switched acute leukemiaJason H Kurzer, Olga K Weinberg
Clinics in Laboratory Medicine|July 22, 2023
Advances in Flow Cytometry for Mixed Phenotype and Ambiguous LeukemiasJason H Kurzer, Olga K Weinberg
Trends in Endocrinology and Metabolism: TEM|December 5, 2006
SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each otherTravis J Maures, Jason H Kurzer, Christin Carter-Su
Molecular and Cellular Biology|August 18, 2006
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active stateJason H Kurzer, Pipsa Saharinen, Olli Silvennoinen, et al.
American Journal of Clinical Pathology|November 13, 2014
Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survivalRyan C Johnson, Jason H Kurzer, Peter L Greenberg, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Blood|September 1, 2022
Visceral leishmaniasis in the differential diagnosis of pancytopeniaYong Tang, Jason H Kurzer
Surgical Pathology Clinics|July 30, 2019
Acute Leukemias of Ambiguous Lineage: Clarification on Lineage SpecificityJason H Kurzer, Olga K Weinberg
Seminars in Diagnostic Pathology|April 14, 2023
Updates in molecular genetics of acute myeloid leukemiaJason H Kurzer, Olga K Weinberg
Frontiers in Oncology|August 12, 2021
<i>PHF6</i> Mutations in Hematologic MalignanciesJason H Kurzer, Olga K Weinberg
Journal of Clinical Pathology|May 27, 2018
Identification of early B cell precursors (stage 1 and 2 hematogones) in the peripheral bloodJason H Kurzer, Olga K Weinberg
International Journal of Laboratory Hematology|June 30, 2022
To B- or not to B-: A review of lineage switched acute leukemiaJason H Kurzer, Olga K Weinberg
Clinics in Laboratory Medicine|July 22, 2023
Advances in Flow Cytometry for Mixed Phenotype and Ambiguous LeukemiasJason H Kurzer, Olga K Weinberg
Trends in Endocrinology and Metabolism: TEM|December 5, 2006
SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each otherTravis J Maures, Jason H Kurzer, Christin Carter-Su
Molecular and Cellular Biology|August 18, 2006
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active stateJason H Kurzer, Pipsa Saharinen, Olli Silvennoinen, et al.
American Journal of Clinical Pathology|November 13, 2014
Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survivalRyan C Johnson, Jason H Kurzer, Peter L Greenberg, et al.
Pageof 3